February 2, 2026 — Leads & Copy —
South San Francisco, CA — Twist Bioscience Corporation (NASDAQ: TWST) released its financial results and business highlights for the first quarter of fiscal year 2026, which ended December 31, 2025, the company announced today.
A conference call and live audio webcast will be held at 8:00 a.m. Eastern Time today for analysts and investors to discuss the company’s financial results and business update. The live webcast can be accessed through the Investor Relations section of Twist Bioscience’s website. Parties interested in telephone participation must register on the Company’s Investor Relations website to receive the dial-in number and a unique PIN number. Participants are encouraged to dial in fifteen minutes before the scheduled start time. The webcast replay will be available for two weeks.
The detailed fiscal first quarter 2026 earnings report and the investor presentation can be found on the Events and Presentations page of the Investor Relations section under the “Company” tab at www.twistbioscience.com.
Twist Bioscience works in service of customers who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals and defense, the company’s customers are developing ways to better lives and improve the sustainability of the planet by using Twist Bioscience’s synthetic DNA tools.
Twist Bioscience’s silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to its customers. The company’s platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis, sequencing and therapeutics discovery, providing both the quality and quantity of the tools needed to rapidly realize the opportunity ahead.
Source: Twist Bioscience
